Andre Albergaria

Summary

Affiliation: Institute of Molecular Pathology and Immunology
Country: Portugal

Publications

  1. ncbi p63 expression in normal skin and usual cutaneous carcinomas
    Jorge S Reis-Filho
    IPATIMUP, Institute of Molecular Pathology and Immunology, University of Porto, Portugal
    J Cutan Pathol 29:517-23. 2002
  2. ncbi Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
    Andre Albergaria
    Institute of Molecular Pathology and Immunology of Porto University, Porto, Portugal
    BMC Cancer 11:299. 2011
  3. ncbi Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
    Andre Albergaria
    Development Domain, Institute of Life and Health Sciences ICVS, School of Health Sciences of Minho University, Campus de Gualtar, Braga, Portugal
    Breast Cancer Res 11:R40. 2009
  4. ncbi ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation
    Andre Albergaria
    Institute of Life and Health Sciences, School of Health Sciences of Minho University, Braga, Portugal
    Hum Mol Genet 19:2554-66. 2010
  5. ncbi P-cadherin expression in breast cancer: a review
    Joana Paredes
    Life and Health Sciences Research Institute ICVS, School of Health Sciences, University of Minho, Campus de Gualtar, 4710 057 Braga, Portugal
    Breast Cancer Res 9:214. 2007
  6. ncbi Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
    Celine Pinheiro
    Life and Health Sciences Research Institute ICVS, School of Health Sciences, University of Minho, Campus of Gualtar, Braga, Portugal
    Histopathology 56:860-7. 2010
  7. ncbi Maspin expression in normal skin and usual cutaneous carcinomas
    Jorge S Reis-Filho
    School of Health Sciences, University of Minho, Braga, Portugal
    Virchows Arch 441:551-8. 2002
  8. ncbi P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation
    Joana Paredes
    Institute of Pathology and Molecular Immunology of Porto University IPATIMUP, Braga, Portugal
    Clin Cancer Res 11:5869-77. 2005

Detail Information

Publications8

  1. ncbi p63 expression in normal skin and usual cutaneous carcinomas
    Jorge S Reis-Filho
    IPATIMUP, Institute of Molecular Pathology and Immunology, University of Porto, Portugal
    J Cutan Pathol 29:517-23. 2002
    ..Scant data on p63 expression in normal skin, basal cell carcinomas (BCCs), keratoacanthomas and squamous cell carcinomas (SCCs) have been reported. We herein evaluated p63 expression in 16 BCCs, one keratoacanthoma and 13 SCCs...
  2. ncbi Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
    Andre Albergaria
    Institute of Molecular Pathology and Immunology of Porto University, Porto, Portugal
    BMC Cancer 11:299. 2011
    ..Hypothetically, this particular tumour dissemination pattern would impair the reliability of using Nottingham Prognostic Index as a tool for triple-negative breast cancer prognostication...
  3. ncbi Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
    Andre Albergaria
    Development Domain, Institute of Life and Health Sciences ICVS, School of Health Sciences of Minho University, Campus de Gualtar, Braga, Portugal
    Breast Cancer Res 11:R40. 2009
    ..The purpose of this study was to explore if the expression of FOXA1 and GATA-3 may provide an opportunity to stratify subsets of patients that could have better outcome, among the ERalpha-negative/poor prognosis breast cancer group...
  4. ncbi ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation
    Andre Albergaria
    Institute of Life and Health Sciences, School of Health Sciences of Minho University, Braga, Portugal
    Hum Mol Genet 19:2554-66. 2010
    ..CDH3 GenBank accession no. NT_010498...
  5. ncbi P-cadherin expression in breast cancer: a review
    Joana Paredes
    Life and Health Sciences Research Institute ICVS, School of Health Sciences, University of Minho, Campus de Gualtar, 4710 057 Braga, Portugal
    Breast Cancer Res 9:214. 2007
    ....
  6. ncbi Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
    Celine Pinheiro
    Life and Health Sciences Research Institute ICVS, School of Health Sciences, University of Minho, Campus of Gualtar, Braga, Portugal
    Histopathology 56:860-7. 2010
    ..However, their role in solid tumours is still poorly understood. Thus, the present work aimed to contribute to understanding the involvement of MCT1 and MCT4 in breast cancer progression as well as MCT regulation by CD147...
  7. ncbi Maspin expression in normal skin and usual cutaneous carcinomas
    Jorge S Reis-Filho
    School of Health Sciences, University of Minho, Braga, Portugal
    Virchows Arch 441:551-8. 2002
    ..No correlation with other clinical pathological features was observed. Our findings do not support the role of maspin as a tumor suppressor gene and suggest that this serpin is probably associated with specific lines of differentiation...
  8. ncbi P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation
    Joana Paredes
    Institute of Pathology and Molecular Immunology of Porto University IPATIMUP, Braga, Portugal
    Clin Cancer Res 11:5869-77. 2005
    ..Another purpose was to evaluate the P-cadherin promoter methylation pattern as the molecular mechanism underlying this gene regulation...